Skip to main content
SpringerLink
Log in

PERTUSSIS VACCINE: BENEFIT APPEARS TO OUTWEIGH THE RISK

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

PERTUSSIS VACCINE: BENEFIT APPEARS TO OUTWEIGH THE RISK. Inpharma Wkly. 310, 2–3 (1981). https://doi.org/10.1007/BF03313981

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03313981

Keywords

Search

Navigation